MAINEGENERAL HEALTH IN THE US SELECTS SECTRA’S ENTERPRISE IMAGING SAAS TO HELP RADIOLOGISTS IMPROVE DIAGNOSTIC SPEED DESPITE GROWING DEMANDS

SHELTON, Conn., Oct. 15, 2024 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide US healthcare provider MaineGeneral Health its enterprise imaging as a fully hosted public cloud service, Sectra One Cloud. The comprehensive solution will provide radiologists diagnostic speed while the service enhances security and scalability.

“We’re excited to implement Sectra’s advanced enterprise imaging solution,” says Mark St. John, CIO at MaineGeneral Health. “The system has the potential to replace some of what we currently use for other specialties, including cardiology, oncology and pathology. Sectra has an excellent reputation for service, reliability, and continuously improving their products and services.”

Based in Augusta, MaineGeneral Health serves central Maine through a network of hospitals and outpatient facilities. In September 2024, they signed a 5-year agreement for Sectra One Cloud, and will utilize the modules for radiology and breast imaging, as well as the vendor-neutral archive (VNA). MaineGeneral Health performs approximately 200,000 exams annually. 

“Radiologists everywhere face high demands and need solutions that help maintain diagnostic speed. That speed isn’t just about how quickly images load. It’s also about system reliability, having advanced clinical tools at your fingertips, and features that ensure each case is read by the right person at the right time. Sectra One Cloud addresses these needs, helping MaineGeneral optimize workflows and support their mission of delivering excellent healthcare,” says Isaac Zaworski, President of Sectra, Inc.

Sectra’s enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in “Best in KLAS”.

About Sectra
With over 30 years of innovation and more than 2,500 installations around the globe, Sectra is a leading imaging IT provider to health systems worldwide. Sectra offers a complete enterprise solution comprised of imaging modules (radiology, cardiology, pathology, orthopedics, and ophthalmology), and a robust VNA. Over the last consecutive eleven years, Sectra has been awarded Best in KLAS for highest customer satisfaction. For more information, visit Sectra’s website.

Contact
Torbjörn Kronander, President and CEO
Sectra AB
E-mail: torbjorn.kronander@sectra.se 
Phone: +46 705 23 5227

Photo – https://healthtechnologynet.com/wp-content/uploads/2024/10/Sectra.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2024/10/Sectra_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/mainegeneral-health-in-the-us-selects-sectras-enterprise-imaging-saas-to-help-radiologists-improve-diagnostic-speed-despite-growing-demands-302276256.html

SOURCE Sectra, Inc

Staff

Recent Posts

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

2 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

2 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

2 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

2 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

2 hours ago

Anti-Snoring Mouthpiece vs Nose Strips: Consumer Analysis Explains Why Product Format May Matter More Than Brand

How Jaw-Positioning Devices and Nasal Products Differ — SleepZee Examined Within Mouthpiece Category ContextChicago, IL,…

2 hours ago